Zacks Investment Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-637
| Closed | -$229K | – | 686 |
|
2021
Q4 | $229K | Sell |
637
-7
| -1% | -$2.52K | ﹤0.01% | 574 |
|
2021
Q3 | $210K | Buy |
+644
| New | +$210K | ﹤0.01% | 573 |
|
2019
Q2 | – | Sell |
-2,900
| Closed | -$828K | – | 633 |
|
2019
Q1 | $828K | Buy |
2,900
+94
| +3% | +$26.8K | 0.02% | 417 |
|
2018
Q4 | $912K | Buy |
2,806
+83
| +3% | +$27K | 0.02% | 362 |
|
2018
Q3 | $1.23M | Sell |
2,723
-76
| -3% | -$34.2K | 0.03% | 365 |
|
2018
Q2 | $1.15M | Buy |
+2,799
| New | +$1.15M | 0.02% | 392 |
|
2018
Q1 | – | Sell |
-5,042
| Closed | -$945K | – | 644 |
|
2017
Q4 | $945K | Sell |
5,042
-4,569
| -48% | -$856K | 0.02% | 414 |
|
2017
Q3 | $1.62M | Sell |
9,611
-6,093
| -39% | -$1.03M | 0.04% | 283 |
|
2017
Q2 | $2.25M | Buy |
+15,704
| New | +$2.25M | 0.06% | 219 |
|
2016
Q4 | – | Sell |
-3,271
| Closed | -$421K | – | 765 |
|
2016
Q3 | $421K | Sell |
3,271
-8,342
| -72% | -$1.07M | 0.01% | 463 |
|
2016
Q2 | $1.27M | Sell |
11,613
-3,732
| -24% | -$408K | 0.04% | 283 |
|
2016
Q1 | $1.46M | Buy |
+15,345
| New | +$1.46M | 0.05% | 256 |
|